News

Top
News
Kyorin Pharmaceutical Receives Marketing Approval for Oral Quinolone Antibacterial Agent "Lasvic®Tablets 75mg"

Kyorin Pharmaceutical Receives Marketing Approval for Oral Quinolone Antibacterial Agent "Lasvic®Tablets 75mg"

September 20, 2019

Please see the PDF file below for details.

Kyorin Pharmaceutical Receives Marketing Approval for Oral Quinolone Antibacterial Agent "Lasvic®Tablets 75mg" [ 123.8 KB ]